Drew Pratt

3.0k citations

46 papers · 629 indexed · h-index 15

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Genetics 19
- Glioma Diagnosis and Treatment 17
Oncology 15
- Cancer Immunotherapy and Biomarkers 9

Co-authors: Kenneth Aldape (10 shared papers)David E. Kleiner (9 shared papers)Felix Sahm (1 shared paper)Catherine M. Hammack‐Aviran (1 shared paper)David J. Echevarria (1 shared paper)Tim F. Greten (7 shared papers)Austin G. Duffy (7 shared papers)Bradford J. Wood (7 shared papers)
Journals: Journal of Clinical Oncology (6 papers)Neuro-Oncology (3 papers)Acta Neuropathologica (3 papers)Acta Neuropathologica Communications (2 papers)Brain Pathology (2 papers)
Partner nations: United States Germany China

In The Last Decade

Drew Pratt

43 papers receiving 623 citations

Peers

Countries citing papers authored by Drew Pratt

Since Specialization

Citations

This map shows the geographic impact of Drew Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Pratt more than expected).

Fields of papers citing papers by Drew Pratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Pratt. The network helps show where Drew Pratt may publish in the future.

Co-authors

The 25 scholars most cited alongside Drew Pratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Drew Pratt Line = papers co-authored together Drew Pratt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma Cancer Immunology Immunotherapy ·David Agdashian, Mei ElGindi, Changqing Xie, Milan Sandhu, Drew Pratt, David E. Kleiner, William D. Figg, Julie Rytlewski, Catherine Sanders, Erik Yusko, Bradford J. Wood, David Venzon, Gagandeep Brar, Austin G. Duffy, Tim F. Greten, Firouzeh Korangy	2019	103
2	Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas Acta Neuropathologica ·Drew Pratt, Siva Kumar Natarajan, Adam Banda, Caterina Giannini, Pankaj Vats, Carl Koschmann, Rajen Mody, Arul M. Chinnaiyan, Sriram Venneti	2018	47
3	A Novel Behavioral Test Battery to Assess Global Drug Effects Using the Zebrafish International Journal of Comparative Psychology ·David J. Echevarria, Catherine M. Hammack‐Aviran, Drew Pratt, John D. Hosemann	2008	45
4	Combined Small Cell Carcinoma of the Lung: Is It a Single Entity? Journal of Thoracic Oncology ·Xiaoliang Zhao, Justine N. McCutcheon, Bhaskar Kallakury, Joeffrey Chahine, Drew Pratt, Mark Raffeld, Yulong Chen, Changli Wang, Giuseppe Giaccone	2017	42
5	Functional Interaction Between a RARE and an AP-2 Binding Site in the Regulation of the Human HOX A4 Gene Promoter Nucleic Acids Research ·L. F. Doerksen, Anuradha Bhattacharya, Perry Kannan, Drew Pratt, Michael A. Tainsky	1996	39
6	DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology Neuro-Oncology ·Drew Pratt, Felix Sahm, Kenneth Aldape	2021	36
7	Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma Neurosurgery ·Drew Pratt, Gifty Dominah, Graham P. Lobel, Arnold Obungu, John Lynes, Victoria Sánchez, Nicholas Adamstein, Xiang Wang, Nancy A. Edwards, Tianxia Wu, Dragan Maric, Amber Giles, Mark R. Gilbert, Martha Quezado, Edjah K. Nduom	2018	25
8	SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors Neuro-Oncology ·Pooja Panwalkar, Drew Pratt, Chan Chung, Derek Dang, Paul Le, Daniel Martínez, Jill Bayliss, Kyle Smith, Mike Adam, S. Steven Potter, Paul A. Northcott, Leo Mascarenhas, Jared Shows, Bruce Pawel, Ashley Margol, Annie Huang, Alexander R. Judkins, Sriram Venneti	2020	21
9	A pilot study of AMP-224, a PD-L2 Fc fusion protein, in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer. Journal of Clinical Oncology ·Austin G. Duffy, Oxana V. Makarova‐Rusher, Drew Pratt, David E. Kleiner, Suzanne Fioravanti, Melissa Walker, Stephanie Carey, William D. Figg, Seth M. Steinberg, Victoria Anderson, Elliot Levy, Venkatesh Krishnasamy, Bradford J. Wood, Jennifer Jones, Deborah E. Citrin, Tim F. Greten	2016	19
10	Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways Acta Neuropathologica Communications ·Matthew Pun, Drew Pratt, Patricia R. Nano, Piyush Joshi, Li Jiang, Bernhard Englinger, Arvind Rao, Marcin Cieślik, Arul M. Chinnaiyan, Kenneth Aldape, Stefan M. Pfister, Mariella G. Filbin, Aparna Bhaduri, Sriram Venneti	2023	18
11	Autochthonous Chagas Disease — Missouri, 2018 MMWR Morbidity and Mortality Weekly Report ·George Turabelidze, Archana Vasudevan, Christian Rojas‐Moreno, Susan P. Montgomery, Molly Baker, Drew Pratt, Susanne Enyeart	2020	18
12	Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndrome Journal of Cardiovascular Magnetic Resonance ·Andrew Ertel, Drew Pratt, Peter Kellman, Steve Leung, Patricia W Bandettini, Lauren Long, Michael Young, Celeste M. Nelson, Andrew E. Arai, Kirk M. Druey	2015	16
13	A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations Acta Neuropathologica ·Drew Pratt, Chandan Kumar‐Sinha, Marcin Cieślik, Rohit Mehra, Hong Xiao, Lina Shao, Andrea Franson, Evan Cantor, Arul M. Chinnaiyan, Rajen Mody, Zied Abdullaev, Kenneth Aldape, Martha Quezado, Sandra Camelo‐Piragua	2021	16
14	Tremelimumab, a monoclonal antibody against CTLA-4, in combination with subtotal ablation (trans-catheter arterial chemoembolization [TACE], radiofrequency ablation [RFA] or cryoablation) in patients with hepatocellular carcinoma (HCC) and biliary tract carcinoma (BTC). Journal of Clinical Oncology ·Austin G. Duffy, Oxana V. Makarova‐Rusher, Drew Pratt, David E. Kleiner, Suzanne Fioravanti, Melissa Walker, Stephanie Carey, William D. Figg, Seth M. Steinberg, Victoria Anderson, Elliot Levy, Venkatesh Krishnasamy, Bradford J. Wood, Tim F. Greten	2016	16
15	DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival Acta Neuropathologica ·Zhichao Wu, Osório Lopes Abath Neto, Tejus Bale, Jamal Benhamida, Douglas A. Mata, Rust Turakulov, Zied Abdullaev, Daniel F. Marker, Courtney Ketchum, Hye‐Jung Chung, Caterina Giannini, Martha Quezado, Drew Pratt, Kenneth Aldape	2022	15
16	Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma Journal of Neuropathology & Experimental Neurology ·Drew Pratt, Stefania Pittaluga, Maryknoll Palisoc, Patricia Fetsch, Liqiang Xi, Mark Raffeld, Mark R. Gilbert, Martha Quezado	2017	14
17	Genotyping <b><i>FOXG1</i></b> Mutations in Patients with Clinical Evidence of the <b><i>FOXG1</i></b> Syndrome Molecular Syndromology ·Drew Pratt, Janet Warner, Mark Williams	2012	14
18	The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice Scientific Reports ·Luis E.F. Almeida, Jesse M. Damsker, Sarah Albani, Nina Afsar, Sayuri Kamimura, Drew Pratt, David E. Kleiner, Martha Quezado, Heather Gordish‐Dressman, Zenaide Quezado	2018	11
19	Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors Acta Neuropathologica Communications ·Omkar Singh, Drew Pratt, Kenneth Aldape	2021	10
20	Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab BMC Pulmonary Medicine ·Dante A. Suffredini, Jung Min Lee, Cody J. Peer, Drew Pratt, David E. Kleiner, Jason M. Elinoff, Michael A. Solomon	2018	10

About Drew Pratt

Drew Pratt is a scholar working on Genetics, Oncology, Neurology, Nephrology and Molecular Biology, having authored 46 papers that have together received 629 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Cancer Immunotherapy and Biomarkers (9 papers), Chromatin Remodeling and Cancer (8 papers), Epigenetics and DNA Methylation (6 papers), Neurofibromatosis and Schwannoma Cases (4 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Genetics (172 citations), Hepatology (67 citations), Oncology (226 citations), Cancer Research (83 citations) and Immunology (91 citations). Drew Pratt has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Kenneth Aldape, David E. Kleiner, Felix Sahm, Catherine M. Hammack‐Aviran, David J. Echevarria, Tim F. Greten, Austin G. Duffy, Bradford J. Wood, William D. Figg and Martha Quezado. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Acta Neuropathologica, Acta Neuropathologica Communications and Brain Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact